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Advances in microarray technology have made it attractive to combine information on clinical traits, marker
genotypes, and comprehensive gene expression from family studies to dissect complex disease genetics. Without
accounting for family structure, methods that test for association between a trait and gene-expression levels can
be misleading. We demonstrate that the standard unstratified test based on Pearson’s correlation coefficient can
produce spurious results when applied to family data, and we present a stratified family expression association test
(FEXAT). We illustrate the utility of the FEXAT via simulation and an application to gene-expression data from
lymphoblastoid cell lines from four CEPH families. The FEXAT has a smaller estimated false-discovery rate than
the standard test when within-family correlations are of interest, and it detects biologically plausible correlations
between beta catenin and genes in the WNT-activation pathway in humans that the standard test does not.
Traditional statistical techniques for meiotic mapping,
such as linkage analysis and allelic association analysis,
have been very successful at mapping Mendelian dis-
eases—that is, rare diseases caused by rare, highly pen-
etrant alleles at a single locus. They have been much less
successful at mapping complex diseases, which result
from the complex interplay of many loci and environ-
mental factors (Clerget-Darpoux et al. 2001). In part,
this is because genes influence disease via their gene
products: mRNA and, farther downstream, proteins.
These gene products are, in turn, influenced by other
genes and environmental factors. This weakens the sta-
tistical association between variation in alleles in a func-
tionally relevant gene and variation in disease.
New technologies, such as DNA microarrays, measure
the relative abundance of mRNA produced by many
genes simultaneously. This information may be one step
closer to the relevant biology than classically defined
clinical traits and opens up interesting strategies for un-
derstanding complex diseases (Horvath and Baur 2000).
In an increasingly common application, genes are func-
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tionally classified according to their expression across
different conditions (Quackenbush 2001). Researchers
have also begun to map QTLs underlying gene expres-
sion. This has led to the discovery of small regions ap-
parently involved in regulating the expression of a large
number of other genes throughout the genome (Brem et
al. 2002; Schadt et al. 2003). This information can then
be combined with information on clinical-trait QTLs to
discern whether a particular locus plays a direct or regu-
latory role in trait etiology. This approach can produce
a relatively small list of candidate genes in an objective
fashion (Schadt et al. 2003). Alternatively, the typically
large number of candidate genes in regions linked to a
clinical trait can be reduced by restricting attention to
those the expression levels of which show association
with a relevant clinical trait (Wayne and McIntyre 2002).
Patterns of gene expression can also be used to define
subtypes of clinical trait with distinct genetic compo-
nents, potentially increasing the power of clinical-trait
linkage scans (Schadt et al. 2003).
Studies combining clinical trait linkage mapping and
gene-expression data have been successfully completed
using model organisms such as Mus musculus and Dro-
sophila melanogaster (Wayne and McIntyre 2002; Schadt
et al. 2003). Similar studies in humans are on the ho-
rizon. Family-based studies offer opportunities for mul-
tiple analyses: clinical trait linkage mapping, expression
QTL mapping, expression profiling, and trait-expression
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Figure 1 Joint density of Pearson and FEXAT P values under different models for the correlation between expression levels and trait
values. Darker areas represent areas of higher density, estimated from the P values from 10,000 simulated studies of four sibships with 11, 8,
7, and 6 members. The panel for scenario 1 (the null hypothesis) shows that the P value for the FEXAT has a roughly uniform distribution,
as is appropriate, whereas the distribution for the Pearson’s test is skewed toward zero. Under scenario 2 (linear model), both statistics have
high power. When the family means for trait and expression are correlated but within-family differences are not (scenario 3), the FEXAT again
has a uniform distribution, whereas the Pearson P values tend to be small. When the within-family differences are correlated but family means
are not (scenario 4), the FEXAT P values tend to be much smaller than Pearson P values.
association. Methods for expression profiling and testing
for trait-expression association should account for fami-
ly structure. Here, we present a family-based test for
correlation between gene expression and trait values.
The family-based design also makes this test robust to
population stratification bias. We close by briefly dis-
cussing family-based approaches to expression profiling.
Standard unstratified measures of the association be-
tween expression levels and clinical traits—such as Pear-
son’s correlation coefficient (Quackenbush 2001)—do
not take family structure into account. This can lead to
spurious results when the number of families is small
and the bulk of the variance in the trait and expression
levels is due to between-family differences, as opposed
to within-family differences. Furthermore, standard un-
stratified tests may also fail to detect within-family cor-
relation when there is no correlation between gene ex-
pression and the trait between families. We illustrate
these ideas via simulation below.
To account for family structure, we propose a sibship-
stratified family expression association test (FEXAT),
which is a continuous-trait version of the Mantel-Haen-
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Table 1
Power of Nominal .05-Level Tests for the Pearson’s Correlation Test and the FEXAT under Different Models for the
Correlation between Expression Levels and Trait Values
SAMPLE SIZE,
SCENARIO,
AND MODEL
PARAMETERS
POWER FOR MODEL AND TEST
:2 2j j p 1/2m  :
2 2jm j p 1 :
2 2j j p 2m 
Pearson FEXAT Pearson FEXAT Pearson FEXAT
Four sibships:
Scenario 1 .11 .05 .21 .05 .33 .05
Scenario 2:
b p .333 .81 .42 .90 .42 .95 .41
b p .667 1.00 .99 1.00 .98 1.00 .98
Scenario 3:
r p .333m .14 .05 .25 .04 .39 .05
r p .667m .21 .05 .38 .05 .55 .05
Scenario 4:
r p .333 .35 .42 .34 .42 .39 .42
r p .667 .78 .99 .63 .98 .52 .99
Eight sibships:
Scenario 1 .09 .05 .14 .05 .21 .05
Scenario 2:
b p .333 .89 .36 .99 .34 .96 .35
b p .667 1.00 .96 1.00 .96 1.00 .96
Scenario 3:
r p .333m .12 .05 .21 .05 .32 .05
r p .667m .24 .05 .43 .04 .63 .05
Scenario 4:
r p .333 .30 .35 .25 .34 .26 .34
r p .667 .75 .96 .56 .96 .39 .96
NOTE.—Power calculated via simulation. Scenario 1 corresponds to the null model of no correlation between expression
and trait; scenario 2 is a standard linear model; scenario 3 corresponds to a model in which family-specific expression and
trait means are correlated but within-family differences are not; and scenario 4 corresponds to a model in which within-
family differences from the family mean for expression and trait are correlated but the family means are not. : is the2 2j jm 
ratio of variance in family means to variance in within-family differences; thus, when : 2, two-thirds of the variance2 2j j pm 
in expression (trait) is due to variance in the shared family mean. (See text.)
szel test (Mantel 1963). This is a univariate test (looking
for association between one gene-expression level and
the trait) but can be used in the context of high-dimen-
sional gene-expression data from microarrays as a first-
pass analysis to select a subset of mRNAs likely to be
associated with the trait, as is now often done using
standard methods.
Let ,…,I index the sibships in the study (ex-i p 1
tended pedigrees may contribute multiple sibships) and
,…,Ji index the subjects in a sibship. Further, letj p 1
Xij denote the expression level for subject j in family i
and Yij the trait value. Xij could be measured as the (log
of the) fold change of the expression for the gene under
study in the subject’s RNA relative to a reference sample,
as in cDNA arrays (Hedge et al. 2000) or as match-
mismatch score, as in oligonucleotide arrays (Dalma-
Weiszhaus et al. 2002). Then the FEXAT is:
2¯( )[ ]  X Y  Yij ij i7i j
.
1 2 2¯ ¯( ) ( )  X X  Y  Yij i7 ij i7i j jJ  1i
This statistic can be compared with its asymptotic 2x1
distribution or an empirical permutation distribution
(described below) to calculate P values. We motivate this
statistic by noting that the terms in the2¯ X (Y  Y )ij ij i7j
numerator have expectation zero under the null, and the
terms
1 22 ¯( )( )X X Y  Y ij i7 ij i7j jJ  1i
in the denominator are the permutation variances of the
numerator terms. The FEXAT makes no explicit distri-
butional assumptions. It requires only that, conditional
on the observed order statistics, all (Ji!)
2 combinations
within a sibship are equally likely (see, e.g., Cox and
Hinkley 1974, pp. 184–186).
Simulation studies show that the FEXAT on the basis
of the asymptotic critical value has a conservative type I
error–rate size even when the number of families is small
and that it has greater power to detect within-family cor-
relation than Pearson’s correlation test. We simulated
two small studies with 32 observations. The first con-
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Table 2
Power of Nominal .001-Level Tests for the Pearson’s Correlation Test and the FEXAT under Different Models for the
Correlation between Expression Levels and Trait Values
SAMPLE SIZE,
SCENARIO,
AND MODEL
PARAMETERS
POWER FOR MODEL AND TEST
:2 2j j p 1/2m  :
2 2j j p 1m  :
2 2j j p 2m 
Pearson FEXAT Pearson FEXAT Pearson FEXAT
Four sibships:
Scenario 1 .008 .0003 .028 .0003 .090 .0001
Scenario 2:
b p .333 .387 .022 .600 .023 .789 .021
b p .667 .962 .593 .980 .607 .991 .594
Scenario 3:
r p .333m .013 .0001 .048 .0003 .136 .0000
r p .667m .034 .0002 .118 .0002 .266 .0001
Scenario 4:
r p .333 .070 .024 .086 .023 .138 .023
r p .667 .440 .594 .330 .600 .274 .594
Eight sibships:
Scenario 1 .003 .0002 .011 .0002 .027 .0002
Scenario 2:
b p .333 .465 .006 .735 .006 .926 .006
b p .667 .979 .257 .993 .739 .999 .257
Scenario 3:
r p .333m .007 .0002 .023 .0002 .073 .0001
r p .667m .028 .0002 .100 .0001 .260 .0002
Scenario 4:
r p .333 .041 .007 .042 .007 .055 .007
r p .667 .328 .257 .200 .261 .130 .255
NOTE.—Power calculated via simulation. Scenario 1 corresponds to the null model of no correlation between expression
and trait; scenario 2 is a standard linear model; scenario 3 corresponds to a model where family-specific expression and
trait means are correlated but within-family differences are not; and scenario 4 corresponds to a model where within-family
differences from the family mean for expression and trait are correlated but the family means are not. : is the ratio of2 2j jm 
variance in family means to variance in within-family differences; thus, when : , two-thirds of the variance in2 2j j p 2m 
expression (trait) is due to variance in the shared family mean.
Table 3
P Values for the Pearson’s Correlation Test and FEXAT for
Association between Beta-Catenin and Genes Known To Be
Involved in the WNT-Activation Process in Lymphoblastoid Cell
Lines from Four CEPH Families
Gene
P VALUE
Pearson FEXAT
TCF4 .34 .04
LEF1 .08 .07
CTBP2 .21 .03
WNT11 .44 .0002
WISP2 .002 .02
MAP3Ka .36 .01
a Represents the mean P value over 4 of 11 mitogen-activated pro-
tein 3-kinases represented on the microarray.
sisted of four sibships of sizes 11, 8, 7, and 6 (the same
family structure as the CEPH data analyzed below); the
second consisted of eight sibships of size 4. We drew
gene expression levels Xij and trait values Yij from ran-
dom effects model
X m ij xi xijp  ,( ) ( ) ( )Y m ij yi xij
where
2m 0 j r j j xi m m m m xijx x y∼ N , and2( ) ( ) ( ) ( )[ ]m 0 r j j j yi m m m m yijx y y
20 j r j j   x x y∼ N , .2( ) ( )[ ]0 r j j j   yx y
The family mean vectors (mx my)
T and the within-family
differences (x y)
T were assumed to be independent. The
family-mean vectors model within-family similarities in
expression and trait values owing to either shared genes
or environment; the correlation in mean vectors might
be due to confounding factors such as population strati-
fication. We considered four scenarios: (1) no correlation
between Xij and Yij; (2) a linear relationship between Yij
and Xij, individual-level noise; (3) correla-Y p bX ij ij
tion in family expression and trait means but not within-
family differences (i.e., and ); and (4) cor-r ( 0 r p 0m 
relation in within-family expression and trait differences
but not family means (i.e., and ). We fixedr p 0 r ( 0m 
at 1 and varied to inves-2 2 2 2 2 2j p j p j j p j p j x y m mx my
tigate the relative effects of variation in family means
and within-family differences. (Simulations not shown
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Figure 2 WNT11 and SORD mean log expression ratios plotted
against the CTNNB1 expression in four CEPH sibships. Each sibship
is colored a different shade of gray. The FEXAT found WNT11 and
CTNNB1 to be significantly correlated ( ), whereas the stan-P p .0002
dard test did not ( ). The situation was reversed for SORD andP p .44
CTNNB1 (FEXAT ; Pearson ).P p .76 P p .02
varied the ratios : and : . Results did not differ2 2 2 2j j j jx y mx my
qualitatively from those presented here.) For each sce-
nario, we generated 10,000 replicate studies and cal-
culated Pearson and FEXAT correlation tests on the ba-
sis of x1
2 critical values for and .a p .05 a p .001
Simulations and analysis were conducted with the freely
available R software (Ihaka and Gentleman 1996). An R
function to calculate the FEXAT correlation and test is
available at the first author’s Web site.
Simulation results are presented infigure 1 andtables
1 and 2. Under scenario 1, the FEXAT has a conservative
type I error rate, whereas the standard correlation test
is anticonservative, with the type I error rate increasing
as the ratio of between-family variance jm
2 to within-
family variance j
2 increased. Intuitively, when j
2 is small
relative to jm
2, the relevant sample size for the standard
correlation test is the number of families. When this sam-
ple size is small, asymptotic properties fail. In particular,
the four family means (mxi myi)
T may, by chance, fall on
a line, suggesting a linear relationship when, in fact, there
is none. As the number of sibships studied increased, the
type I error associated with the standard correlation test
decreased, although it was still appreciable (110% for
nominal .05-level test) for eight sibships.
Under scenarios 2 and 3, the standard correlation test
has greater power to detect association than the FEXAT.
This is not surprising, since the standard test is optimal
when there is a linear relationship between Xij and Yij,
and the FEXAT, by construction, is not sensitive to cor-
relations in family-mean expression and trait values.
Under scenario 4, when variation in trait values is
associated with variation in within-family differences in
expression, as opposed to across-family differences, the
FEXAT has more power to detect the association between
trait values and gene-expression levels (except when the
nominal test size is 1 and within-family varia-a p .00
tion accounts for the majority of variance in trait and
expression). The relative efficiency increases as the pro-
portion of variance in traits and expression levels owing
to between-family differences increases. This implies that
the FEXAT may have more power than standard cor-
relation tests when both the trait and expression level
under study have high heritabilities or are both sensitive
to differences in shared family environment.
The observed type I error for the FEXAT is slightly
conservative when the nominal rate is but isa p .05
much smaller than the nominal rate when . Thisa p .001
suggests that the tails of the FEXAT distribution are trun-
cated relative to the asymptotic distribution for small sam-
ple sizes. Alternatively, P values can be calculated from
a permutation distribution, as discussed below.
To further examine whether the FEXAT statistic offers
advantages over more classical association-based statis-
tics in the gene expression setting, we considered WNT
signaling in lymphoblastoid cell lines from 32 individ-
uals from four large CEPH sibships (in CEPH/Utah pedi-
grees 1362, 1375, 1377, and 1408). Details concerning
gene-expression measurement are described more fully
elsewhere (Schadt et al. 2003). TheWNT pathway (WNT
signaling transduction) is involved in many different de-
velopmental processes. This pathway serves to regulate
WNT-responsive genes and has been shown to regulate
B lymphocyte proliferation (Reya et al. 2000). Therefore,
we expected the WNT pathway to be activated in the
CEPH lymphoblastoid cell lines, given that these cell
lines had been cultured and maintained in the log phase
of cell growth for at least 2 d before harvest.
Central to activation of the WNT pathway is the for-
mation of a beta-catenin/TCF complex that forms in the
presence of WNT expression, which results in the ac-
tivation of WNT-responsive genes (Seidensticker et al.
2000). In the absence of WNT, the beta-catenin/TCF
complex does not form; instead, another complex forms,
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Figure 3 Number of positive FEXAT and Pearson tests versus the expected number of positive results under the null of no within-family
association (calculated via the permutation procedure described in the text) for critical values, range 0–16.
the beta-catenin deconstruction complex, which pro-
motes the phosphorylation of beta-catenin by Glycogen
synthase kinase 3b (GSK3B). The phosphorylated beta-
catenin becomes multiubiquitinated and is subsequently
degraded in proteasomes (Seidensticker et al. 2000).
Therefore, in the presence of WNT, we would expect
beta-catenin levels to be associated with TCF/LEF1 lev-
els and related factors that can lead to the formation
and stabilization of the beta-catenin/TCF complex. In
the absence of WNT, we would expect levels of beta-
catenin to be associated with genes making up the beta-
catenin deconstruction complex. Treating beta-catenin
as a clinical trait and testing associations with genes
represented in each complex, we applied the FEXAT and
the standard correlation test to determine whether the
activation or deconstruction complexes were active in
the CEPH lymphoblastoid cell lines.
The heritability of beta-catenin (CTNNB1 [GenBank
accession number NM_001904]) over the four CEPH
families was found to be very significant, with a P value
of .00001 (Schadt et al. 2003). We sought to test whether
the high degree of heritability detected for this trait in
such a small number of families translated into FEXAT
statistics that were more significant than standard Pearson
correlation statistics computed between CTNNB1 and
genes known to associate with beta-catenin as part of
beta-catenin deconstruction or the WNT activation path-
way. We computed the Pearson correlation coefficient
and FEXAT statistic between CTNNB1 and seven genes
associated with the beta-catenin deconstruction complex:
GSK3B (GenBank accession number NM_002093), axin
(AXIN1 [GenBank accession number AF009674]),
conductin (AXIN2 [GenBank accession number NM_
004655]), APC (GenBank accession number NM_
000038), and the dishevelled genes DVL1–3 (GenBank
accession numbers NM_004421–3). Neither test statis-
tic was significant at the 0.1 level for any of these genes,
with the exception of APC, which had P values of .04
and .03 for the FEXAT and Pearson test statistics, re-
spectively. It has been established in the literature that
Reports 1329
APC can interact with beta-catenin independently of the
other genes involved in the deconstruction complex (Sei-
densticker et al. 2000). On the other hand, when testing
nine TCF/beta-catenin complexes that bind to DNA and
activate WNT targets, we found significant results for
CTNNB1 interacting with LEF1 (GenBank accession
number NM_016269), TCF4 (GenBank accession num-
ber NM_003199), CTBP2 (GenBank accession number
NM_001329), WNT11 (GenBank accession number
NM_004626), WISP2 (GenBank accession number
NM_003881), and several of the mitogen-activated pro-
tein 3-kinases, all known to be involved in the WNT
activation process (see table 3). Further, we note that, for
most of these genes, the association was significant only
with respect to the FEXAT statistic and not the Pearson
correlation test statistic, so the associations would have
been missed had family structure not been taken into ac-
count. For instance, the FEXAT statistic for the associa-
tion between TCF4 and beta-catenin has a P value of .04,
whereas the P value for the corresponding Pearson cor-
relation test statistic was .34.TCF4 and beta-catenin com-
plexes are among those most central to the activation of
the WNT pathway. (The FEXAT does not achieve the
Bonferroni-corrected level of for any of.05/16 p .003
the genes listed in table 3 other than WNT11. However,
more tests [ MAP3K genes] are significant at8 p 4 4
the .05 level than expected by chance [.8].)
The FEXAT was able to detect biologically plausible
correlations among expression levels for genes involved
in the WNT pathway that Pearson’s correlation did not.
This suggests that gene-expression variations are asso-
ciated with one another by way of within-family differ-
ences for those genes involved in this pathway, not across-
family differences. For example,figure 2 plots the joint
distribution of CTNNB1 and WNT11 expression. The
FEXAT found these two genes to be statistically signifi-
cantly associated ( ), whereas the standard cor-P p .0002
relation test did not ( ). There appears to be aP p .44
positive correlation in at least three of the four sibships—
with the largest sibship having the strongest correla-
tion—although there is no clear overall correlation.
Conversely, the FEXAT did not find sorbitol dehy-
drogenase (SORD) and CTNNB1 to be significantly as-
sociated ( ), although the standard test did (P p .76 P p
). Visual inspection suggests an overall negative cor-.02
relation in SORD and CTNNB1, although they are un-
correlated in each of the sibships (fig. 2). Sorbitol de-
hydrogenase is an enzyme involved in fructose and
mannose metabolism (the polyol pathway). We have no
a priori reason to believe it should be associated with
WNT signaling. Given current knowledge, it is difficult
to definitively exclude this apparent association as a false
positive, but the significant Pearson test should be in-
terpreted cautiously, since it may be a statistical artifact
owing to the chance alignment of sibship means.
We also calculated the expected number of false-posi-
tive tests under the null hypotheses of no within-family
association between CTNNB1 and the other measured
mRNAs. We did this by averaging 1500 random per-
mutations of the trait (CTNNB1) values, where trait
values were permuted within sibships but not between
sibships. This procedure assumes no within-family cor-
relation in trait and expression while conditioning on
possible between-family differences. We emphasize that
the terminology “false positive” is context dependent.
Here, the focus is on within-family correlation, so tests
called significant owing to between-family differences
are “false positives.” If the focus were instead on cor-
relation across families, such significant tests would be
interesting and not “false positives.”
In particular, for a statistic T(Xi, Y) testing association
between the expression for gene i and the trait and a
given critical value t*, the estimated expected number
of significant results under the null is
 1 ∗1{T[X ,p (Y)] t }ij i j
,
J
where j indexes the random permutations p1,…, pJ, and
1[*] is the indicator function. This procedure is similar
to that proposed by Tusher et al. (2001). Permutation
P values can be calculated by comparing the observed
statistic T(X,Y) with the permuted values T(Xi, Y).
Figure 3 plots the number of positive FEXAT and Pear-
son tests for association between CTNNB1 and 24,479
mRNAs versus the number of false positives over the
range of t*. The FEXAT generally has a lower ratio of
expected false positive results to observed positive re-
sults. This is because many of the significant Pearson
statistics reflect between-family associations between the
trait and expression levels. Thus, if within-family cor-
relation is the focus, the FEXAT can be more accurate
(the ratio of “false positive” to positive results is
smaller).
These results suggest that statistical methodologies that
take the stratified nature of family-based studies into
account can usefully complement standard correlation
measures. When the number of independent families sam-
pled is small—as will often be the case, because of the
expense of measuring gene-expression levels—and the
proportion of trait and expression variance owing to
shared genetic and/or environmental factors is high,
standard methods may detect an association between
trait and expression when there is none. Standard meth-
ods may also miss associations primarily owing to
within-family correlation in a trait and gene expression.
We have shown via simulation and a data example that
the proposed FEXAT performs better than standard
methods in these situations.
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Further methodological developments are required,
however. The assumption that all trait and expression
combinations within a sibship are equally likely condi-
tional on the order statistics may not hold. For example,
the gene under study may be linked to a causal gene,
even though it does not play a role in determining the
trait itself. If gene-expression levels depend on a particu-
lar polymorphism in the gene under study, then all trait
and expression combinations will not be equally likely
for sibships of size 12 (Kraft 2001). Replacing the vari-
ance estimates in the denominator of the FEXAT with
the empirical estimates does not re-2¯[ X (Y  Y )]ij ij i7j
quire that the combinations within a family be equally
likely, but the resulting statistic performed poorly when
the number of families sampled was small. It had very
low power (results not shown).
We have focused on continuous traits. The FEXAT
can be easily modified to accommodate categorical out-
comes Yij. For example, in the dichotomous disease, Yij
could be set to 1 for subjects with disease and to 0 for
those without. Further extensions might include tests for
effect modification owing to measured environmental or
genetic covariates.
The primary application of the FEXAT described in
this report is to test for correlations between gene ex-
pression levels and continuous traits, possibly including
other gene-expression levels, as a method to identify can-
didate genes associated with a clinical trait of interest.
The FEXAT approach could also be used to define a prox-
imity measure between different genes on the basis of
the within-family correlation in their expression levels;
this proximity measure could then be used to cluster
genes, just as Pearson’s correlation coefficient is used now
for tissue samples from unrelated individuals (Quack-
enbush 2001). The authors’ FEXAT function currently
estimates the within-family correlation as:
¯( )  X Y  Yij ij i7i j
.2 2¯ ¯ ( ) ( )  X X  Y  Yij i7 ij i7i j j
This is simply the average within-family covariance
divided by the square root of the average product of the
within-family trait and expression variances. The FEXAT
correlation may uncover patterns in gene expression in
families missed by Pearson’s correlation coefficient.
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